DelveInsight

DelveInsight, a prominent business consulting and market research firm, distinguishes itself by seamlessly merging industry expertise with insightful market analysis methodologies to furnish crucial insights to top-tier decision-makers. The organization's mission centers around assisting its clientele in the acquisition of pertinent information, thereby enhancing their decision-making capabilities. DelveInsight is adept at recognizing potential market opportunities, conducting competitor assessments, and undertaking comprehensive evaluations of the business environment. Notably, DelveInsight serves as a trusted and informed partner, offering invaluable support in shaping business strategies and conducting market research across the entire drug value chain.

DelveInsight's primary conduit for delivering intelligent information to professionals in both the business and healthcare sectors is through its meticulously crafted analytical and strategic reports. Presently, DelveInsight boasts a diverse portfolio encompassing over 3,000 Marketed and Pipeline Reports. These reports are thoughtfully categorized based on parameters such as indication, mechanism of actions, drugs, global API manufacturers, and specialized reports focusing on pivotal areas such as Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy, and other emerging domains. This robust platform has become the go-to resource for numerous enterprises seeking to transform and redefine their business strategies.

DelveInsight's offerings extend beyond reports to encompass Consulting Projects and Competitive Intelligence services, catering to the multifaceted needs of its clientele. Moreover, the organization is dedicated to providing tailor-made research services that align with the specific interests and requirements of its clients. DelveInsight's commitment to excellence and innovation positions it as a trusted partner in the areas of business strategy and market research.

View recent articles by this publisher on our blog:
The Power of Digital Therapeutics in Mental Health
Anti-VEGF Therapies: Forever Market Rulers of Wet-AMD Treatment?
Additional articles from this publisher

...Show More ...Show Less

8,636 Reports from DelveInsight

   
  • High-Grade Glioma - Market Insight, Epidemiology And Market Forecast - 2034

    High-Grade Glioma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the total market size of high-grade glioma accounted for ~USD 830 million in the 7MM. Only 5% of new investigational drug applications submitted to the US FDA for cancer therapies are successful, and ... Read More

  • Chronic Venous Insufficiency - Market Insight, Epidemiology And Market Forecast - 2034

    Chronic Venous Insufficiency - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the total market size of Chronic Venous Insufficiency accounted for ~USD 2000 million in the 7MM. According to DelveInsight’s estimates, in 2023, there were approximately 470 million total ... Read More

  • Presbyopia - Market Insight, Epidemiology And Market Forecast - 2034

    Presbyopia - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, the total diagnosed prevalent cases of presbyopia in the 7MM, were ~278 million; the number of these cases is expected to increase by 2034. In 2023, the market size of presbyopi ... Read More

  • Idiopathic Membranous Nephropathy Market Insight, Epidemiology And Market Forecast - 2032

    Idiopathic Membranous Nephropathy Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Idiopathic Membranous Nephropathy (IMN) is a significant type of glomerular disease characterized by the presence of large amounts of protein in the urine (nephrotic syndrome) and is primarily an ... Read More

  • Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034

    Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Fuchs Endothelial Corneal Dystrophy (FECD) market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of FECD in the 7MM is expect ... Read More

  • Peripheral Neuropathic Pain - Market Insight, Epidemiology And Market Forecast - 2034

    Peripheral Neuropathic Pain - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Peripheral neuropathic pain (PNP) results from lesions to the peripheral nervous system caused by mechanical trauma, metabolic diseases, neurotoxic chemicals, infection, or tumor invasion. Peripheral ... Read More

  • Systemic Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2034

    Systemic Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Systemic lupus erythematosus is an autoimmune disorder characterized by antibodies to nuclear and cytoplasmic antigens, multisystem inflammation, protean clinical manifestations, and a relapsing and r ... Read More

  • Systemic Sclerosis Market Insight, Epidemiology And Market Forecast - 2034

    Systemic Sclerosis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the total market size of systemic sclerosis was nearly USD 1,850 million in the 7MM. The largest market size was captured by the US. Among EU4 and the UK, Italy accounted for the largest market size, w ... Read More

  • Herpes Simplex - Market Insight, Epidemiology And Market Forecast - 2034

    Herpes Simplex - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, approximately 232,853 thousand seroprevalent cases of Herpes Simplex existed in the 7MM, these cases are expected to decrease during the forecast period (2024–2034). The decline in seroprevalent cases of ... Read More

  • Axial Spondyloarthritis - Market Insight, Epidemiology And Market Forecast - 2034

    Axial Spondyloarthritis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Axial spondyloarthritis is a multifactorial disease characterized by inflammation in sacroiliac joints and spine, bone reabsorption, and aberrant bone deposition, which may lead to ankylosis. Disease pat ... Read More

  • Neurotrophic Keratitis Market Insight, Epidemiology And Market Forecast - 2034

    Neurotrophic Keratitis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Neurotrophic keratitis was highest in the US among the 7MM, accounting for approximately USD 743 million which is further expected to increase by 2034. In 2023, the prevalence of ... Read More

  • Mydriasis - Market Insight, Epidemiology And Market Forecast - 2034

    Mydriasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Mydriasis market is set for steady growth, with a compound annual growth rate (CAGR) expected to remain strong from 2024 to 2034. This growth will be driven primarily by the increase in age-related eye conditions ... Read More

  • Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034

    Traumatic Brain Injury - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Traumatic Brain Injury market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Traumatic Brain Injury in the 7MM is expected to increase, driven ... Read More

  • Menkes Disease- Market Insights, Epidemiology and Market Forecast– 2034

    Menkes Disease- Market Insights, Epidemiology and Market Forecast– 2034 Key Highlights: Menkes disease diagnosed prevalence is expected to rise, driven by advancements in genetic testing, increased awareness, improved survival rates, genetic factors, expanded screening, and environmental influences. ... Read More

  • Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034

    Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The market size for ACC in the 7MM is anticipated to grow at a significant CAGR throughout the forecast period (2024–2034). This growth is attributed to the rising number of incident cases, the launch o ... Read More

  • Hidradenitis Suppurativa Market Insight, Epidemiology And Market Forecast - 2034

    Hidradenitis Suppurativa Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights To put the market opportunity for hidradenitis suppurativa into perspective for a condition that affects roughly 1% of the population, it is clear that, with the right strategy, it has the potential to be ... Read More

  • Nontuberculous Mycobacterial (NTM) Infections - Market Insight, Epidemiology And Market Forecast - 2034

    Nontuberculous Mycobacterial (NTM) Infections - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The NTM Infections market is poised for steady growth, with a compound annual growth rate (CAGR) expected to remain strong during the forecast period (2024–2034). This growth will b ... Read More

  • Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology And Market Forecast - 2034

    Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the total market size for NMIBC in the 7MM was approximately USD 2,350 million. This is expected to grow in the coming years due to the increasing prevalence of NMIBC, the launc ... Read More

  • Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2034

    Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for multiple myeloma was estimated to be nearly USD 21,300 million in 2023, which is expected to show positive growth by 2034, owing to rise in incident cases, label expansion and ... Read More

  • Molybdenum Cofactor Deficiency Type-A (MoCoD-A) - Market Insights, Epidemiology, and Market Forecast–2034

    Molybdenum Cofactor Deficiency Type-A (MoCoD-A) - Market Insights, Epidemiology, and Market Forecast–2034 Key Highlights Attributed to the rising diagnosed prevalent cases and increasing awareness, the Molybdenum Cofactor Deficiency Type A (MoCoD-A) market was valued at nearly USD 12 million in 2023 ... Read More

  • Postherpetic Neuralgia - Market Insight, Epidemiology And Market Forecast - 2034

    Postherpetic Neuralgia - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, United States accounted for the largest market size in 2023, with approximately 70% of the total market size. Postherpetic neuralgia occurs in a subset of the population suffering from an epis ... Read More

  • Sickle Cell Disease (SCD) - Market Insight, Epidemiology And Market Forecast - 2034

    Sickle Cell Disease (SCD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Sickle cell disease (SCD) is a genetic blood disorder characterized by the presence of abnormal hemoglobin, causing red blood cells to become sickle-shaped. SCD is a global health concern, particularly ... Read More

  • PD-(L)1 Inhibitors – Market Insight, Epidemiology and Market Forecast – 2034

    PD-(L)1 Inhibitors – Market Insight, Epidemiology and Market Forecast – 2034 Key Highlights The market size of PD-(L)1 inhibitors in the 7MM was nearly USD 36 billion in 2023, and the largest market size was generated by the United States. Clinical trials testing of PD-(L)1 inhibitors have tripled i ... Read More

  • Acne Vulgaris Market Insight, Epidemiology And Market Forecast - 2034

    Acne Vulgaris Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, there were approximately 29,433 thousand diagnosed prevalent cases of acne vulgaris in the 7MM, these cases are further expected to increase during the forecast period (2024–2034). Factors contributing to t ... Read More

  • Prader-Willi Syndrome Market Insight, Epidemiology And Market Forecast - 2034

    Prader-Willi Syndrome Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, in the 7MM the total market size of PWS was more than USD 600 million. PWS is a multifaceted genetic disorder characterized by a range of challenging symptoms, including hyperphagia (excessive hunge ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings